Is Sentinel Lymph Node Biopsy Reliable After Recent Oncoplastic Breast Reduction?

The American surgeon 2023 Vol.89(5) p. 2056-2058

Martin TA, Choudhry S, Holton LH, Tafra L, Jackson RS

관련 도메인

Abstract

An oncoplastic breast reduction may disrupt normal lymphatic drainage and make subsequent identification of the sentinel lymph nodes (SLNs) unreliable. There are little data on the success rate of sentinel lymph node biopsy (SLNB) after recent oncoplastic breast reduction, and there is no agreement on whether SLNB should be done at the time of the partial mastectomy and reduction for ductal carcinoma in situ (DCIS). The primary goals of this study were to evaluate the identification rate of SLNB after recent oncoplastic or functional breast reduction and to examine recurrence rates in this setting. Results reveal SLNB is feasible in this setting. At least one SLN was found in all patients, and there were no recurrences with an average follow-up of 34 months.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 breast reduction 유방성형술 dict 4
해부 breast 유방 dict 4
약물 SLNB → sentinel lymph node biopsy C0796693
Sentinel Lymph Node Biopsy
scispacy 1
질환 ductal carcinoma C1176475
Ductal Carcinoma
scispacy 1
질환 SLNs → sentinel lymph nodes scispacy 1
질환 SLNB → sentinel lymph node biopsy scispacy 1
질환 DCIS → ductal carcinoma in situ scispacy 1
질환 SLN scispacy 1
기타 Lymph Node scispacy 1
기타 lymphatic scispacy 1
기타 lymph nodes scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Female; Sentinel Lymph Node Biopsy; Lymphatic Metastasis; Breast Neoplasms; Mastectomy; Mammaplasty; Lymph Nodes; Axilla

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문